|
 |
AdalimumabThis page contains recent news articles, when available, and an overview of Adalimumab but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Adalimumab (when available) Used in the treatment of rheumatoid arthritis. Elevated levels of TNF are found in the synovial fluid of rheumatoid arthritis patients and play an important role in both the pathologic inflammation and the joint destruction that are hallmarks of the disease. Adalimumab binds specifically to TNF-alpha and blocks its general cytokine effects, thereby reducing TNF-induced inflammation and halting the joint destruction. For treatment of rheumatoid arthritis Mechanism Of Action: Adalimumab binds to TNF-alpha and blocks its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also lyses surface TNF expressing cells in vitro in the presence of complement. News Articles on Adalimumab Federal Court Upholds $1.7 Billion Patent Award to Centocor - Nov 11, 2009 The lawsuit, filed in 2007, alleges that Abbott willfully infringed the Centocor's patent by manufacturing Humira (adalimumab), a tumor necrosis factor ... FDA news (subscription) Findings Suggest That Adalimumab Exposure in Early Pregnancy Does Not Increase ... - Oct 28, 2009 ..."But so far we have seen no pattern in malformations for adalimumab-treated versus other women." The study is being conducted by the Organization of ... DG News Long-Term Registry Study Confirms Safety of Adalimumab for Patients With ... - Oct 26, 2009 SAN DIEGO -- October 26, 2009 -- The first results from a post-approval safety study of adalimumab for Crohn's disease (CD), ... DG News Abbott Submits Marketing Authorization Application of Humira® (adalimumab), a ... - Oct 29, 2009 Adalimumab is a monoclonal antibody that neutralizes the activity of tumor necrosis factor alpha (TNF-), a protein that plays a central role in inflammatory ... PharmiWeb.com (press release) TB risk varies between anti-TNFs - Nov 1, 2009 Infliximab and adalimumab are associated with a three- to four-fold higher rate of tuberculosis compared to etanercept, data from the British Society for ... Rheumatology Update Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money - Nov 10, 2009 ...doctors an alternative to the $10 billion-a-year class of biotech drugs, like Amgen's etanercept (Enbrel) and Abbott Laboratories' adalimumab (Humira). ... Xconomy No Increased Cancer Risk with Anti-TNF Therapy in RA - Oct 29, 2009 However, during the first year after starting treatment the risk was lower with etanercept (RR 0.43, 95% CI 0.22 to 0.84) and higher with adalimumab (RR ... MedPage Today Study Links Rheumatoid Arthritis Drug Adherence to Improved Medical Outcomes ... - Oct 19, 2009 The study examined differences in RA patient medication adherence, use of medical services, and treatment costs when patients using either adalimumab ... Reuters Decision Resources: Biosimilars may cause biotech companies to lose more than ... - Nov 11, 2009 TNF-alpha inhibitors include Enbrel (etanercept), by Amgen and Eli Lilly & Co., Abbott's Humira (adalimumab) and Remicade (infliximab), ... Drug Store News (blog) High Court rejects B-MS bid for NICE legal challenge - Nov 10, 2009 At the time, the Institute argued that it had already given the OK to Abbott Laboratories' Humira (adalimumab), Wyeth's Enbrel (etanercept) and ... Pharma Times REG-Pfizer Inc CP-690550, Pfizer's Oral JAK Inhibitor, Demonstrates Response ... - Oct 18, 2009 This study also included adalimumab (40 mg subcutaneously every other week) as an active control in the first 12 weeks of the study. ... Reuters Centocor Says Long-Term Data Shows Improvements In Simponi-treated Rheumatoid ... - Oct 19, 2009 Findings from the study demonstrated that patients with RA previously treated with adalimumab, etanercept or infliximab responded to, and maintained ... RTT News ACR: Saving Knees from OA May Break the Bank - Oct 22, 2009 Adalimumab (Humira), for example, which had been studied as a possible treatment for osteoarthritis, retails for about $1600 per month, according to the ... MedPage Today New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis - Oct 19, 2009 ...that patients with RA previously treated with adalimumab, etanercept or infliximab responded to, and maintained response to, SIMPONI through one year. ... Reuters ACR: Rheumatoid Arthritis Biologics Increase Risk of Skin Cancer - Oct 18, 2009 ...infliximab (Remicade) or adalimumab (Humira), when compared to 3515 patients who were treated with more traditional, disease-modifying anti-rheumatic ... MedPage Today Polyarticular JIA: The Elusive Quest for Disease Remission - Nov 2, 2009 ...and 11.5% with an anti-tumor necrosis factor (TNF) medication such as etanercept, infliximab, or adalimumab within the first six months of care. ... AAP Grand Rounds (registration) HGSI's Phase III Benlysta Details Boost Confidence in Second Trial - Oct 20, 2009 Abbott, of Abbott Park, Ill., presented data showing that Humira (adalimumab) plus methotrexate decreased rheumatoid arthritis progression as well as joint ... BioWorld Online ACR: JAK Inhibitor Shows Continued Response in RA - Oct 19, 2009 Anti-tumor necrosis factor drugs such as adalimumab (Humira) are injected. Kremer and colleagues enrolled 507 patients with active rheumatoid arthritis in a ... MedPage Today ACR70-disease activity score remission achievement from switches between all ... - Nov 3, 2009 Results: 9 articles were included: switch from etanercept and/or infliximab and/or to adalimumab is effective with an ACR70 response from 5% to 33%. ... 7thSpace Interactive (press release) Centocor reports positive data from two Phase III arthritis trials - Oct 21, 2009 Findings from the Go-After study demonstrated that patients with RA previously treated with adalimumab, etanercept or infliximab responded to, ... Trading Markets (press release) Revolutionary New Treatment for Sciatica Advances in the Clinic - Oct 27, 2009 Kume, K., et al., The efficacy and safety of caudal epidural injection with the TNF-antagonist, adalimumab and etanercept, in patients with ... PR Web (press release) Artritis psoriásica, Artritis reumatoide en combinación con metotrexato ... - Oct 18, 2009 Artritis psoriásica y espondilitis anquilosante : 40 mg (dosis única) vÃa SC en semanas alternas Adalimumab es un anticuerpo monoclonal humano recombinante ... Las Provincias ê±´ì„ Â·í?¬ë¡ 병 시장 '휴미ë?¼' 주ë?„ - Nov 10, 2009 ...ê±´ì„ ê³¼ í?¬ë¡ 병 ì¹˜ë£Œì œ 시장ì—?ì„œ TNF-알파 ì–µì œì œì?˜ 사용ì?´ ì¦?ê°€í•˜ê³ ìžˆëŠ” 가운ë?° 특히 '휴미ë?¼'(Humira, adalimumab)ê°€ 시장ì?„ 주ë?„í• ì „ë§?ì?´ë‹¤. ... 디지틀보사 류마티스 치료 '엔브ë ?ì—?ì„œ ì•…í…œë?¼ë¡œ' - Nov 4, 2009 ...디시즌리소스가 미êµì—?ì„œ ì?˜ì‚¬ë“¤ì?„ 대ìƒ?으로 조사한 ê²°ê³¼ì—? ì?˜í•˜ë©´ 엔브ë ?, '휴미ë?¼'(Humira, adalimumab), 'ë ˆë¯¸ì¼€ì?´ë“œ'(Remicade, infliximab) 등 기존ì?˜ TNF-알파 ... 디지틀보사 Tratamento para a artrite reumatóide não aumenta risco de cancro - Nov 6, 2009 ...iniciado a terapia com bloqueadores do TNF-alfa, nomeadamente com o infliximab, adalimumab ou o etanercept, entre Janeiro de 1999 e Julho de 2006. ... RCM Pharma Assessment of radiographic progression in the spines of patients ... - Aug 24, 2009 The fully human anti-tumor necrosis factor (anti-TNF) antibody adalimumab reduces the signs and symptoms and improves overall quality of life in patients 7thSpace Interactive (press release) B-MS hopes early-use label change will boost Orencia sales - Aug 27, 2009 Amgen and Wyeth's Enbrel (etanercept) and Abbott Laboratories' Humira (adalimumab). Second-quarter sales of Orencia increased 40% to $148 million. Pharma Times French and Benelux stocks - Factors to watch on Aug 5 - Aug 5, 2009 Anti-TNF drugs include Johnson & Johnson's Simponi or golimumab; Abbott Laboratories' Humira or adalimumab; UCB SA's Cimzia or certolizumab pegol; Forbes Abrupt-Onset Obsessive-Compulsive Disorder (OCD) in a Child With ... - Aug 17, 2009 His medications included methotrexate 7.5 mg weekly, adalimumab 10 mg biweekly, and multivitamin supplements. He laughed about his Crohn's disease being "a Psychosomatics (subscription) Physical function, disease activity, and health-related quality-of ... - Aug 17, 2009 IntroductionWe evaluated the 3-year impact of adalimumab on patient-reported physical function and health-related quality-of-life (HRQOL) outcomes in 7thSpace Interactive (press release) Guiding RA Patients Through Medicare Maze Toward Payment for ... - Aug 26, 2009 In particular they focused on the Part D cost-sharing scenarios for use of adalimumab and etanercept for low-income individuals. Although it appeared that Medscape TNF blockers linked to cancer risk in children & teens - Aug 5, 2009 ...risk of lymphoma and other cancers associated with the use of drugs like Remicade [infliximab] and Humira [adalimumab] in children and adolescents. Gerson Lehrman Group Biotech arthritis drugs get cancer warning - Aug 5, 2009 ...by the agency's decision are Remicade (infliximab), Enbrel (etancercept), Humira (adalimumab), Cimzia (certolizumab pegol) and Simponi (golimumab). Examiner.com 'The drugs I am taking for my skin problems make me feel unwell' - Aug 23, 2009 Humira (adalimumab) is one of a new class of biologic treatments specifically designed to treat psoriasis; it is not helpful in eczema. Telegraph.co.uk Inflammatory Bowel Disease - New product launches - Aug 28, 2009 Cimzia (certolizumab) is better able to compete with Abbott's Humira (adalimumab) in Crohn's disease with its new pre-filled syringe formulation. PRMinds (press release) Officials strengthen cancer warnings for arthritis drugs - Aug 20, 2009 Five prescription TNF blockers are authorized for use in Canada: Enbrel (etancercept), Remicade (infliximab), Humira (adalimumab), Simponi (golimumab) and CTV.ca FDA Issues Multiple Safety Alerts, Updates - Aug 18, 2009 Drugs affected include infliximab (Remicade), etancercept (Enbrel), adalimumab (Humira), certolizumab pegol (Cimzia) and golimumab (Simponi). AAFP News Now Risk associated with every decision we make - Aug 16, 2009 The TNF blockers include infliximab (), etanercept (), adalimumab (), certolizumab pegol (), and golimumab (). Therefore, everyone who has taken or might fwdailynews.com TNF Blockers Required to Update Labels to Include Cancer Warnings - Aug 13, 2009 The TNF blockers that are on the market today and must include the new boxed warnings on their labels are: Humira (adalimumab), Remicade (infliximab), InjuryBoard.com FDA Update - Aug 11, 2009 The drugs in this class include infliximab (Remicade), etanercept (Enbrel), adalimumab (Humira), certolizumab pegol (Cimzia), and golimumab (Simponi). National Cancer Institute - NCI Cancer Bulletin Unique development: Pyoderma gangrenosum appear during ulcerative ... - Aug 4, 2009 Infliximab, etanercept and adalimumab are nonapproved biologic drugs that have been used in the treatment of sterile inflammatory diseases with cutaneous Modern Medicine Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis ... - Aug 4, 2009 ...[marketed as Remicade(R) (infliximab), Enbrel(R) (etanercept), Humira(R) (adalimumab), Cimzia(R) (certolizumab pegol) and Simponi(R) (golimumab)]. PR Newswire (press release) EMEA makes adverse drug reaction research a priority - Aug 11, 2009 They include tocilizumab (Roche's RoActemra), infliximab (Schering-Plough's Remicade), etanercept (Wyeth's Enbrel) and adalimumab (Abbott's Humira). Pharmafocus Risk of tuberculosis from arthritis medication examined - Aug 8, 2009 ...patients receiving anti-TNF monoclonal antibody therapy (infliximab or adalimumab) than for those receiving soluble TNF receptor therapy (etanercept). The Virtual Medical Centre New Report Just Published Commercial Insight: Psoriasis ... - Aug 11, 2009 The withdrawal of Genentech/Merck Serono's Raptiva (efalizumab) in Q1 2009 is predicted to benefit both Abbott's Humira (adalimumab) and Johnson & Johnson's Live-PR.com (Pressemitteilung) Justiça manda PR dar remédio para doença rara a adolescente - Aug 28, 2009 ...medicamento especÃfico (Adalimumab) a um adolescente de 14 anos que sofre de uma inflamação no intestino, crônica e rara, chamada doença de Crohn. Terra Brasil Anti-Inflamatory Drugs Could Raise the Risk of Teen and Childhood ... - Aug 9, 2009 The FDA has put out new warnings about using TNF blockers (Simponi, Humira, Enbrel, Cimzia, Rimicade) due to the risk of developing lymphoma and other TestCountry.com 'ì˜¤ë Œì‹œì•„' ì ?ì?‘ì¦?ì—? 'ê´€ì ˆì—¼ì¹˜ë£Œ 효과' 추가 표시 - Aug 28, 2009 ...ê²½ìŸ?ì œí’ˆì?€ Johnson & Johnson ê³¼ Schering-Plough사ì?˜ Remicade(infliximab), Amgenê³¼ Wyeth사ì?˜ Enbrel(etanercept), Abbott Laboratories사ì?˜ Humira(adalimumab) 메디포뉴스 CientÃficos buscan tratamientos - Aug 27, 2009 Al respecto, el doctor Rafael MartÃn-GarcÃa señala que el Adalimumab es la última alternativa en terapias biológicas que podrÃan dar una esperanza a los Diario Ojo FDA erweitert Krebswarnung bei TNF-Blockern - Aug 5, 2009 Hier sind in den USA neben Etanercept, Adalimumab und Infliximab auch Certolizumab (Cimzia®) und Golimumab (Simponi®) zugelassen. Neu ist die Erkenntnis, Deutsches Ärzteblatt Gyulladásgátló: rákveszélyre figyelmeztet a hatóság - Aug 11, 2009 E gyógyszerosztály tagjainak hatóanyagai az infliximab az etancercept , az adalimumab, a certolizumab pegol és a golimumab. Az FDA intézkedésének alapjául Weborvos 美 TNF ì°¨ë‹¨ì œ 소아 ì•” 위험 - Aug 5, 2009 ...ì?´ë²ˆ ê²½ê³ ê°€ ì ?ìš©ë?˜ëŠ” ì¹˜ë£Œì œë¡œëŠ” 'ë ˆë¯¸ì¼€ì?´ë“œ'(Remicade, infliximab), '심í?¬ë‹ˆ'(Simponi, golimumab), '엔브ë ?'(Enbrel, etanercept), '휴미ë?¼'(Humira, adalimumab) 디지틀보사 Fármacos artritis elevan riesgo de cáncer en niños: FDA de EEUU - Aug 4, 2009 También se encuentran en esta clase Humira de Abbott Laboratories, o adalimumab; Cimzia de UCB SA, o certolizumab pegol; y Enbrel de Amgen Inc y Wyeth, Reuters América Latina å…¨ç?ƒåŒ»è?¯å¸‚场：å?‘下的曲线 ç–²æ€?下å¥?å“?强音 - Aug 26, 2009 ...这些产å“?åˆ†åˆ«æ˜¯åŸºå› æ³°å…‹å’Œç½—æ°?çš„Avastin（bevacizumab）；雅培和å?«æ??çš„Humira（adalimumab）；赛诺è?²å®‰ä¸‡ç‰¹çš„Lovenox（enoxaparinï¼‰ï¼›åŸºå› æ³°å…‹ã€?ç½—æ°?å’Œæ¦ç”° 中国生物技术信息网 Leczenie choroby LeÅ›niowskiego-Crohna utrudniajÄ… formalnoÅ›ci - Aug 14, 2009 Terapia biologiczna z wykorzystaniem specyficznych przeciwciaÅ‚ anty TNF mysio-ludzkich (infliksymab) lub caÅ‚kowicie ludzkich (adalimumab) jest sprawdzonÄ… Gazeta.pl “A mi enfermedad no hay que tenerle miedo, solo respetoâ€?, declaró ... - Aug 12, 2009 Últimamente se han desarrollado las llamadas terapias biológicas, como el infliximab y el adalimumab, que consiguen detener la inflamación, Urgente 24 Mise à jour concernant l'innocuité des inhibiteurs du facteur de ... - Aug 20, 2009 Il existe actuellement cinq inhibiteurs du FNT dont la vente est autorisée au Canada : Enbrel (étancercept), Remicade (infliximab), Humira (adalimumab), Maketwire (Communiqué de presse) TNF-blokkers en een verhoogd risico op leukemie en psoriasis - Aug 5, 2009 In Nederland zijn op dit moment drie TNF-blokkers geregistreerd: etanercept (Enbrel), adalimumab (Humira) en infliximab (Remicade). Ze zijn geïndiceerd voor apothekersnieuws.nl Brand Names/Synonyms: Adalimumab is also known by the following brand names and/or synonyms: Ig gamma-1 chain C region; Humira (Abbott Laboratories) Drug Category: Adalimumab is categorized under the following by the FDA: Immunomodulatory Agents; Antirheumatic Agents; unclassified therapeutic agents (92:00.00) Dosage Forms: Solution Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Humanized anti-TNF antibody (D2E7) |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
